{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T13:40:05Z","timestamp":1718113205816},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1097\/mpa.0000000000000439","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T14:50:54Z","timestamp":1443538254000},"page":"228-233","source":"Crossref","is-referenced-by-count":2,"title":["Increased Serum Insulin Exposure Does Not Affect Age or Stage of Pancreatic Adenocarcinoma Diagnosis in Patients With Diabetes Mellitus"],"prefix":"10.1097","volume":"45","author":[{"given":"David T.","family":"Chao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilesh H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert J.","family":"Zeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Bahary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Whitcomb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall E.","family":"Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210212","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1101\/gad.1415606","article-title":"Genetics and biology of pancreatic ductal adenocarcinoma.","volume":"20","author":"Hezel","year":"2006","journal-title":"Genes Dev"},{"key":"R2-10-20210212","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014.","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"R3-10-20210212","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/gutjnl-2012-303108","article-title":"International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.","volume":"62","author":"Canto","year":"2013","journal-title":"Gut"},{"key":"R4-10-20210212","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1001\/jama.2009.886","article-title":"Body mass index and risk, age of onset, and survival in patients with pancreatic cancer.","volume":"301","author":"Li","year":"2009","journal-title":"JAMA"},{"key":"R5-10-20210212","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/ajg.2012.288","article-title":"Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study.","volume":"107","author":"Anderson","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R6-10-20210212","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/jama.1995.03520440059037","article-title":"Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.","volume":"273","author":"Everhart","year":"1995","journal-title":"JAMA"},{"key":"R7-10-20210212","first-page":"2219","article-title":"Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozotocin-diabetic rats.","volume":"6","author":"Ooi","year":"1992","journal-title":"Mol Endocrinol"},{"key":"R8-10-20210212","doi-asserted-by":"crossref","first-page":"18868","DOI":"10.1016\/S0021-9258(18)55144-9","article-title":"Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1.","volume":"266","author":"Powell","year":"1991","journal-title":"J Biol Chem"},{"key":"R9-10-20210212","first-page":"2007","article-title":"Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles.","volume":"55","author":"Bergmann","year":"1995","journal-title":"Cancer Res"},{"key":"R13-10-20210212","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2165\/00003495-200262120-00007","article-title":"Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus.","volume":"62","author":"Wagstaff","year":"2002","journal-title":"Drugs"},{"key":"R14-10-20210212","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update.","volume":"137","author":"Kirpichnikov","year":"2002","journal-title":"Ann Intern Med"},{"key":"R15-10-20210212","first-page":"303","article-title":"The mechanism of alpha-glucosidase inhibition in the management of diabetes.","volume":"18","author":"Bischoff","year":"1995","journal-title":"Clin Invest Med"},{"key":"R16-10-20210212","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.gastro.2011.02.018","article-title":"Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies.","volume":"141","author":"Elashoff","year":"2011","journal-title":"Gastroenterology"},{"key":"R17-10-20210212","first-page":"F77","article-title":"GLP1 and cancer: friend or foe Endocr Relat Cancer.","volume":"19","author":"Vangoitsenhoven","year":"2012","journal-title":""},{"key":"R18-10-20210212","first-page":"1080","article-title":"(Aus der UAW-Datenbank: Pankreaskarzinome im Zusammenhang mit Exenatid (Byetta)).","volume":"108","year":"2011","journal-title":"Dtsch Arztebl"},{"key":"R19-10-20210212","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1369\/jhc.2008.951319","article-title":"Expression of the GLP-1 receptor in mouse, rat, and human pancreas.","volume":"56","author":"Tornehave","year":"2008","journal-title":"J Histochem Cytochem"},{"key":"R20-10-20210212","doi-asserted-by":"crossref","first-page":"f1263","DOI":"10.1136\/bmj.f1263","article-title":"GLP-1 based agents and acute pancreatitis: drug safety falls victim to the three monkey paradigm.","volume":"346","author":"Gale","year":"2013","journal-title":"BMJ"},{"key":"R21-10-20210212","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMp1314078","article-title":"Pancreatic safety of incretin-based drugsFDA and EMA assessment.","volume":"370","author":"Egan","year":"2014","journal-title":"N Engl J Med"},{"key":"R22-10-20210212","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ajg.2011.483","article-title":"Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis.","volume":"107","author":"Bodmer","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R23-10-20210212","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.","volume":"3","author":"Decensi","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"R24-10-20210212","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/j.gastro.2009.04.013","article-title":"Antidiabetic therapies affect risk of pancreatic cancer.","volume":"137","author":"Li","year":"2009","journal-title":"Gastroenterology"},{"key":"R25-10-20210212","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3892\/or.2012.1890","article-title":"Metformin inhibits the development and metastasis of ovarian cancer.","volume":"28","author":"Wu","year":"2012","journal-title":"Oncol Rep"},{"key":"R26-10-20210212","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s13300-011-0005-0","article-title":"Emerging role of insulin with incretin therapies for management of type 2 diabetes.","volume":"2","author":"Ahluwalia","year":"2011","journal-title":"Diabetes Ther"},{"key":"R27-10-20210212","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4158\/EP11290.OR","article-title":"Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient setting.","volume":"18","author":"Lando","year":"2012","journal-title":"Endocr Pract"},{"key":"R29-10-20210212","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamainternmed.2013.2720","article-title":"Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study.","volume":"173","author":"Singh","year":"2013","journal-title":"JAMA Intern Med"},{"key":"R30-10-20210212","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.2337\/db11-1109","article-title":"Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.","volume":"61","author":"Gier","year":"2012","journal-title":"Diabetes"},{"key":"R31-10-20210212","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.2337\/db09-0058","article-title":"Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin.","volume":"58","author":"Matveyenko","year":"2009","journal-title":"Diabetes"},{"key":"R32-10-20210212","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00125-009-1515-4","article-title":"Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas.","volume":"53","author":"Nachnani","year":"2010","journal-title":"Diabetologia"},{"key":"R33-10-20210212","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2337\/db12-1686","article-title":"Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors.","volume":"62","author":"Butler","year":"2013","journal-title":"Diabetes"},{"key":"R34-10-20210212","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/dia.2013.0177","article-title":"An analysis of characteristics of subjects examined for incretin effects on pancreatic pathology.","volume":"15","author":"Harja","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"R35-10-20210212","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet"},{"key":"R36-10-20210212","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/ijc.24927","article-title":"Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies.","volume":"126","author":"Rinaldi","year":"2010","journal-title":"Int J Cancer"},{"key":"R37-10-20210212","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1158\/1055-9965.EPI-04-0561","article-title":"Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.","volume":"14","author":"Schernhammer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R38-10-20210212","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0092-8674(88)90571-5","article-title":"Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes.","volume":"53","author":"Almoguera","year":"1988","journal-title":"Cell"},{"key":"R39-10-20210212","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.","volume":"4","author":"Hingorani","year":"2003","journal-title":"Cancer Cell"},{"key":"R40-10-20210212","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0006-291X(03)00107-4","article-title":"Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPFVEGF expression in a pancreatic carcinoma cell line.","volume":"302","author":"Zeng","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R41-10-20210212","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3748\/wjg.v16.i15.1854","article-title":"Insulin-like growth factor-I receptor in proliferation and motility of pancreatic cancer.","volume":"16","author":"Tomizawa","year":"2010","journal-title":"World J Gastroenterol"},{"key":"R42-10-20210212","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1023\/A:1026122421369","article-title":"Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma.","volume":"48","author":"Hakam","year":"2003","journal-title":"Dig Dis Sci"},{"key":"R43-10-20210212","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2613.2002.00237.x","article-title":"Serum and tissue level of insulin-like growth factor-I (IGF-I) and IGF-I binding proteins as an index of pancreatitis and pancreatic cancer.","volume":"83","author":"Karna","year":"2002","journal-title":"Int J Exp Pathol"},{"key":"R44-10-20210212","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1055-3207(18)30283-7","article-title":"Role of growth factors in pancreatic cancer.","volume":"7","author":"Korc","year":"1998","journal-title":"Surg Oncol Clin N Am"},{"key":"R45-10-20210212","doi-asserted-by":"crossref","first-page":"8203","DOI":"10.1038\/sj.onc.1205044","article-title":"Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2.","volume":"20","author":"Nair","year":"2001","journal-title":"Oncogene"},{"key":"R46-10-20210212","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1002\/cncr.26661","article-title":"Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.","volume":"118","author":"Valsecchi","year":"2012","journal-title":"Cancer"},{"key":"R47-10-20210212","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","article-title":"The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.","volume":"52","author":"Currie","year":"2009","journal-title":"Diabetologia"},{"key":"R48-10-20210212","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00125-009-1418-4","article-title":"Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study.","volume":"52","author":"Hemkens","year":"2009","journal-title":"Diabetologia"},{"key":"R49-10-20210212","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.canep.2011.05.013","article-title":"Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer.","volume":"36","author":"Dong","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"R50-10-20210212","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/j.gastro.2007.10.040","article-title":"Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.","volume":"134","author":"Chari","year":"2008","journal-title":"Gastroenterology"},{"key":"R51-10-20210212","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/MPA.0b013e3182a9ad9d","article-title":"Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.","volume":"42","author":"Andersen","year":"2013","journal-title":"Pancreas"},{"key":"R52-10-20210212","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/annonc\/mds140","article-title":"Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-control Consortium (PanC4).","volume":"23","author":"Duell","year":"2012","journal-title":"Ann Oncol"},{"key":"R54-10-20210212","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/dmrr.2260","article-title":"Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c).","volume":"28","author":"Ewald","year":"2012","journal-title":"Diabetes Metab Res Rev"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000000439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T12:58:10Z","timestamp":1718110690000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201602000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000000439","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}